Angion Biomedica Corp reports results for the quarter ended in December - Earnings Summary

Elicio Therapeutics

30/03/2022 22:50

* Angion Biomedica Corp  ANGN.OQ  reported quarterly
adjusted
earnings of 58 cents​​ per share for the quarter ended in
December. The mean expectation of four analysts for the quarter
was for a loss of 62 cents per share.
    * Revenue rose 5,551.6% to $25.94 million from a year ago; 
analysts expected $1.74 million. 
    * Angion Biomedica Corp's reported EPS for the quarter was
58
cents​.
    * The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Angion Biomedica Corp shares had fallen by 22.4% this
quarter.
    * The company reported quarterly net income of $14.89
million.
    * Wall Street's median 12-month price target for Angion
Biomedica
Corp is $8.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 30 at 09:49 p.m.  ​All
figures in US dollars unless otherwise stated